Author
Listed:
- Zameer Shervani
(Food Energy Security Research Product Centre, Japan / INTI International University, Malaysia)
- Shagufta Nazneen Ansari
(Integral University, India)
- Mohd Rizwan Jameel
(Centre for Interdisciplinary Research in Basic Science, India / International Centre for Genetic Engineering and Biotechnology, India)
- Aamir A. Khan
(Ross University School of Medicine, USA)
- Intazam Khan
(Progressive Neurology-Astoria, USA)
- Deepali Bhardwaj
(Centre for Skin and Hair Pvt. Ltd., India)
- Parangimalai Diwakar Madan Kumar
(RagasDental College and Hospital, India)
- Akram Mohammad
(University of Ottawa, Canada)
Abstract
The COVID-19 pandemic, caused by SARS-CoV-2, resulted in a large number of deaths worldwide. Based on global data from Japan, France, Germany, the UK, the US, and India, we calculated the % case-to-fatality ratio (CFR). We conducted a comparative study among global, European, American, and Asian countries. The fatality rates for 2020, 2022, 2023, and 2025 were compared. The selected countries also partially illustrate the pandemic’s impact on both rich and poor nations. Japan had the lowest fatality rate (0.2%) followed by France and Germany (0.4%). The fatality rate in the UK was the same as that in the global tally (0.9%). Both the US and India have mortality ratios in the range of 1.1% to 1.2%. Excluding Japan, Germany, and France, the fatality rate is around 1.0%, reported globally, in the UK, the US, and India. For the three years of the pandemic (2020–2023), the percentage of relative risk reduction (RRR%), representing the fatality rate reduction, was in the following order: India had the lowest reduction in death risk (29.81%), whereas Japan had the highest reduction (96.80%). The other countries listed in order of relative risk reduction are France (95.93%), Global (92.88%), Germany (90.75%), the UK (86.11%), and the US (65.04%). This study examines all three major waves of the pandemic that have occurred globally through 2025. In India, three main variants appeared in sequence: Wuhan from May 2020 to January 2021, Delta from March 2021 to October 2021, and Omicron from January 2022 to March 2022. The peaks of these waves were observed in mid-September 2020, the first week in May 2021, and the last week in January 2022. The major waves in the US ended in March 2022. The study covered all major waves worldwide and in the aforementioned countries.
Suggested Citation
Zameer Shervani & Shagufta Nazneen Ansari & Mohd Rizwan Jameel & Aamir A. Khan & Intazam Khan & Deepali Bhardwaj & Parangimalai Diwakar Madan Kumar & Akram Mohammad, 2025.
"COVID-19 Fatality Rate: A 1% Chance of Dying,"
European Journal of Medical and Health Sciences, European Open Science, vol. 7(6), pages 84-90, November.
Handle:
RePEc:epw:ejmed0:v:7:y:2025:i:6:id:42446
DOI: 10.24018/ejmed.2025.7.6.2446
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:ejmed0:v:7:y:2025:i:6:id:42446. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejmed .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.